Browse All / Modules / Osteoporosis Bone Resorption Module

Osteoporosis Bone Resorption Module

Module osteoporosis_bone_resorption 2 disorders Pathograph 5
A conserved metabolic bone-disease module representing the imbalance between osteoclastic bone resorption and osteoblastic bone formation that produces low bone mass and skeletal fragility. Across postmenopausal (estrogen-deficient), senile, glucocorticoid-induced, and genetic/secondary osteoporoses, the initiating lesion converges on the basic multicellular unit: tightly coupled remodeling becomes uncoupled, RANKL-driven osteoclastogenesis is enhanced relative to Wnt-driven osteoblast formation, and net negative bone balance with microarchitectural deterioration follows. Individual disorder entries declare conformance via conforms_to on their pathophysiology nodes, substituting the disorder-specific upstream driver (estrogen withdrawal, glucocorticoid excess, Wnt-pathway or collagen gene defect) while preserving the conserved resorption/formation-imbalance chain.
⚙

Pathophysiology Nodes

5
5 shared nodes are defined in this module.
◉

Cell Types

3
Osteoblast CL:0000062 Osteocyte CL:0000137 Osteoclast CL:0000092
⇄

Biological Processes

5
Bone Remodeling GO:0046849 DYSREGULATED Osteoclast Differentiation GO:0030316 INCREASED Bone Resorption GO:0045453 INCREASED Ossification GO:0001503 DECREASED Bone Mineralization GO:0030282 DECREASED
i

Notes

This is a mechanism module, not a specific disease. Disorder entries reference individual nodes via conforms_to (e.g., "osteoporosis_bone_resorption#Increased Osteoclastic Bone Resorption"). Conforming nodes should substitute the disorder-specific driver of the remodeling imbalance: estrogen deficiency in postmenopausal osteoporosis, Wnt/Dkk1 suppression in glucocorticoid-induced osteoporosis, and LRP5/WNT1 or COL1A1/COL1A2 variants in monogenic low-bone-mass disorders.
↗

Used By Disorder Entries

2
Osteogenesis Imperfecta Type VI via RANKL-Mediated Osteoclast Overactivation → Increased Osteoclastic Bone Resorption
Osteoporosis via Microgravity-Accelerated Bone Resorption → Increased Osteoclastic Bone Resorption
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence-backed metadata.
Pathograph: causal mechanism network for Osteoporosis Bone Resorption Module Interactive directed graph showing how this shared module's pathophysiology nodes connect.
⚙

Pathophysiology

5
Bone Remodeling Imbalance
trigger
The bone remodeling cycle normally tightly couples osteoclastic resorption to osteoblastic formation within the basic multicellular unit, governed by the RANK/RANKL/osteoprotegerin and canonical Wnt signaling axes. The initiating lesion of osteoporosis is disruption of this coupling so that the resorption and formation arms are no longer balanced, regardless of whether the upstream driver is hormonal, pharmacological, or genetic.
Osteoblast CL:0000062 Osteocyte CL:0000137
Bone Remodeling GO:0046849 DYSREGULATED
Downstream
  • RANKL-Driven Osteoclastogenesis
RANKL-Driven Osteoclastogenesis
amplifier
Loss of remodeling coupling shifts the RANKL/OPG ratio toward RANKL, the critical uncoupling factor that drives differentiation and survival of osteoclasts from myeloid precursors. Estrogen deficiency raises RANKL and lowers OPG; glucocorticoid excess likewise enhances RANKL and suppresses OPG, converging on enhanced osteoclastogenesis.
Osteoclast CL:0000092
Osteoclast Differentiation GO:0030316 INCREASED
Downstream
  • Increased Osteoclastic Bone Resorption
Increased Osteoclastic Bone Resorption
central effector
Expanded and activated osteoclasts digest mineralized bone matrix at a rate that exceeds osteoblastic replacement. This is the central effector step of the module: resorption that is normally balanced by an equal wave of formation now outpaces it, eroding trabecular and cortical bone.
Osteoclast CL:0000092
Bone Resorption GO:0045453 INCREASED
Used by disorders
Osteogenesis Imperfecta Type VI as RANKL-Mediated Osteoclast Overactivation
Osteoporosis as Microgravity-Accelerated Bone Resorption
Downstream
  • Impaired Osteoblastic Bone Formation
Impaired Osteoblastic Bone Formation
effector
In parallel with excess resorption, osteoblastic bone formation and mineralization are inadequate to refill resorption cavities. Glucocorticoid excess upregulates Dickkopf-1 and inhibits Wnt signaling to reduce osteoblast differentiation, while estrogen deficiency removes a pro-osteogenic Wnt/BMP stimulus. The result is reduced ossification relative to the resorptive load.
Osteoblast CL:0000062
Ossification GO:0001503 DECREASED Bone Mineralization GO:0030282 DECREASED
Downstream
  • Net Bone Loss and Skeletal Fragility
Net Bone Loss and Skeletal Fragility
consequence
Sustained imbalance between excess resorption and deficient formation produces net negative bone balance, loss of bone mineral density, and deterioration of trabecular and cortical microarchitecture. The accumulated structural deficit reduces bone strength and predisposes to low-trauma fractures, the defining clinical consequence of osteoporosis.
Bone Remodeling GO:0046849 DYSREGULATED